Winch Advisory Services’s Revance Therapeutics, Inc. RVNC Stock Holding History

Winch Advisory Services’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$3K	–	475
2019 Q1	$3K	Hold	200	–	–	﹤0.01%	304
2018 Q4	$4K	Hold	200	–	–	﹤0.01%	252
2018 Q3	$5K	Hold	200	–	–	﹤0.01%	236
2018 Q2	$5K	Hold	200	–	–	﹤0.01%	235
2018 Q1	$6K	Hold	200	–	–	﹤0.01%	217
2017 Q4	$7K	Hold	200	–	–	﹤0.01%	204
2017 Q3	$6K	Hold	200	–	–	﹤0.01%	202
2017 Q2	$5K	Hold	200	–	–	﹤0.01%	222
2017 Q1	$4K	Hold	200	–	–	﹤0.01%	215
2016 Q4	$4K	Hold	200	–	–	﹤0.01%	198
2016 Q3	$3K	Hold	200	–	–	﹤0.01%	222
2016 Q2	$3K	Hold	200	–	–	﹤0.01%	215
2016 Q1	$3K	Hold	200	–	–	﹤0.01%	183
2015 Q4	$7K	Hold	200	–	–	0.01%	154
2015 Q3	$6K	Hold	200	–	–	0.01%	151
2015 Q2	$6K	Hold	200	–	–	﹤0.01%	200
2015 Q1	$4K	Buy	+200	New	+$3.46K	﹤0.01%	212
2014 Q4	–	Sell	-200	Closed	-$4K	–	186
2014 Q3	$4K	Buy	200 +100	+100%	+$2.61K	﹤0.01%	187
2014 Q2	$3K	Buy	+100	New	+$3.13K	﹤0.01%	224

Other funds holding RVNC

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Winch Advisory Services's RVNC Position: Q2 2019 in Review

Winch Advisory Services sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2019, closing a stake of 200 shares — an estimated $3K sold.

Winch Advisory Services first reported a position in RVNC in Q2 2014 and held it in 19 quarters. The position peaked at $7K in Q4 2017. 114 funds tracked by Wall St. Rank hold RVNC as of Q2 2019.

Winch Advisory Services reported no remaining Revance Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Winch Advisory Services sold 200 Revance Therapeutics, Inc. shares in Q2 2019, an estimated $3K.
Winch Advisory Services first reported a position in Revance Therapeutics, Inc. in Q2 2014 and held it in 19 quarters.
Winch Advisory Services's Revance Therapeutics, Inc. position peaked at $7K in Q4 2017.
114 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2019.

Based on Winch Advisory Services's 13F filing for Q2 2019, filed 7 Aug 2019.